Relacorilant
CORT125134-456
Phase 3 small_molecule completed
Quick answer
Relacorilant for Hypercortisolism is a Phase 3 program (small_molecule) at CORCEPT THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CORCEPT THERAPEUTICS INC
- Indication
- Hypercortisolism
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed